FDA Animal Drug User Fee Program Reauthorized by Senate Committee
April 8, 2013
The Senate Health, Education, Labor and Pensions Committee reauthorized the Animal Drug User Fee Act on March 21. Created in 2003, the program allows the Food and Drug Administration (FDA) to collect user fees from drug manufacturers in order to reduce backlog of applications for new animal drug approvals. The program is set to expire on October 1, 2013.
The FDA’s Center for Veterinary Medicine completed its recommendations to Congress for the reauthorization in consultation with key industry stakeholders at the end of February. The Animal Health Institute, the American Veterinary Medical Association and many livestock groups, including NMPF, supported the legislation.
An amendment by Sens. Kirsten Gillibrand (D-N.Y.) and Dianne Feinstein (D-Calif.) to require FDA to annually report the amount of antibiotic sales to farms failed. The Pew Charitable Trusts backed the amendment, and vowed to push the issue again when voted on by the full Senate.